Novel Pirna MW557525 Regulates the Growth of Piwil2-iCSCs and Maintains Their Stem Cell Pluripotency.

Liming Jin,Zhaoxia Zhang,Zhang Wang,Xiaojun Tan,Zhaoying Wang,Lianju Shen,Chunlan Long,Guanghui Wei,Dawei He
DOI: https://doi.org/10.1007/s11033-022-07443-9
IF: 2.7422
2022-01-01
Molecular Biology Reports
Abstract:BACKGROUND:CSCs play an important role in tumor development. Some studies have demonstrated that piRNAs participate in the progression of various cancers. However, the detailed function of piRNAs in CSCs requires further investigation. This study aimed to investigate the significance of novel piRNA MW557525, one of the top five up-regulated piRNAs screened by gene chip and it has been verified by RT-q-PCR that it is indeed the most obvious up-regulated expression in Piwil2-iCSCs.METHODS AND RESULTS:Differentially expressed piRNAs in Piwil2-iCSCs were screened by gene chip. Target genes were predicted by the miRanda algorithm and subjected to GO and KEGG analysis. One of the differential piRNAs, novel piRNA MW557525, was transfected and its target gene NOP56 was silenced in Piwil2-iCSCs, respectively. RT-qPCR, western blot (WB) and dual luciferase reporter assay were used to investigate the interaction of piRNA MW557525 and NOP56. We identified the effect of piRNA MW557525 and NOP56 knockdown on cell proliferation, migration, invasion, and apoptosis via CCK-8, transwell assay, and flow cytometry. The expressions of CD24, CD133, KLF4, and SOX2 were detected via WB. The results showed that piRNA MW557525 was negatively correlated with NOP56, and it promoted the proliferation, migration, invasion, and inhibited apoptosis in Piwil2-iCSCs, and it also promoted the expressions of CD24, CD133, KLF4, and SOX2, while NOP56 showed the opposite effect.CONCLUSIONS:These findings suggested that novel piRNA MW557525 might be a novel therapeutic target in Piwil2-iCSCs.
What problem does this paper attempt to address?